Related Experiment Video
Updated: Feb 19, 2026
08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
82.0K
Extensively drug resistant tuberculosis in Mali: a case report
Bassirou Diarra1,2, Yacouba Toloba3, Bakary Konate4
1University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali. bdiarra@icermali.org.
BMC Research Notes
|November 8, 2017
Summary
Drug resistant tuberculosis is a significant global health concern. This report details two extensively drug-resistant tuberculosis cases in Mali, emphasizing urgent needs for improved diagnostics and treatment programs.
Area of Science:
- Medicine
- Public Health
- Infectious Diseases
Background:
- Drug-resistant tuberculosis (DR-TB) poses a substantial global public health challenge.
- The increasing prevalence of DR-TB necessitates enhanced surveillance and management strategies.
Purpose of the Study:
- To report the first two cases of extensively drug-resistant tuberculosis (XDR-TB) diagnosed in Bamako, Mali.
- To highlight potential nosocomial transmission and delayed treatment initiation in XDR-TB patients.
Main Methods:
- Case presentation of two patients diagnosed with XDR-TB.
- Genotypic analysis to investigate transmission pathways.
- Review of treatment timelines and diagnostic delays.
Main Results:
- The first documented cases of XDR-TB in Bamako, Mali.
- Evidence suggesting nosocomial transmission and superinfection between patients.
- A significant delay of 10 months between diagnosis and initiation of appropriate treatment.
Conclusions:
- Improved diagnostic and treatment algorithms are crucial for effective DR-TB surveillance in Mali.
- Prioritization of programmatic management of drug-resistant tuberculosis is essential to strengthen national TB control efforts.
- Urgent action is needed to address treatment delays and improve patient outcomes for XDR-TB.
Related Concept Videos
01:28Pulmonary Tuberculosis V
656
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
656
01:26Pulmonary Tuberculosis IV
557
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
557
01:29Pulmonary Tuberculosis I
1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
01:28Pulmonary Tuberculosis II
1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
01:31Pulmonary Tuberculosis III
1.1K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.1K